相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。NRAS-Mutated Rhabdomyosarcoma Cells Are Vulnerable to Mitochondrial Apoptosis Induced by Coinhibition of MEK and PI3Kα
Nadezda Dolgikh et al.
CANCER RESEARCH (2018)
Expression of Androgen Receptor and Cancer Stem Cell Markers (CD44+/CD24-and ALDH1+): Prognostic Implications in Invasive Breast Cancer
Nazia Riaz et al.
TRANSLATIONAL ONCOLOGY (2018)
Cancer stem cells: The root of tumor recurrence and metastases
Claudia Peitzsch et al.
SEMINARS IN CANCER BIOLOGY (2017)
Cancer stem cells, cancer-initiating cells and methods for their detection
Shiva Akbari-Birgani et al.
DRUG DISCOVERY TODAY (2016)
Dual PI3K-and mTOR-inhibitor PI-103 can either enhance or reduce the radiosensitizing effect of the Hsp90 inhibitor NVP-AUY922 in tumor cells: The role of drug-irradiation schedule
Cholpon S. Djuzenova et al.
ONCOTARGET (2016)
Emerging Role of mTOR in the Response to Cancer Therapeutics
Erika Ilagan et al.
TRENDS IN CANCER (2016)
FDA Approval: Idelalisib Monotherapy for the Treatment of Patients with Follicular Lymphoma and Small Lymphocytic Lymphoma
Barry W. Miller et al.
CLINICAL CANCER RESEARCH (2015)
PtdIns(3,4,5)P3-Dependent Activation of the mTORC2 Kinase Complex
Pengda Liu et al.
CANCER DISCOVERY (2015)
PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting
Lauren M. Thorpe et al.
NATURE REVIEWS CANCER (2015)
Tackling the cancer stem cells - what challenges do they pose?
Diwakar R. Pattabiraman et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Understanding and targeting cancer stem cells: therapeutic implications and challenges
Ke Chen et al.
ACTA PHARMACOLOGICA SINICA (2013)
Synthesis and Cancer Stem Cell-Based Activity of Substituted 5-Morpholino-7H-thieno[3,2-b]pyran-7-ones Designed as Next Generation PI3K Inhibitors
Guillermo A. Morales et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Dual Inhibition of PI3K and mTOR Mitigates Compensatory AKT Activation and Improves Tamoxifen Response in Breast Cancer
Xiaosong Chen et al.
MOLECULAR CANCER RESEARCH (2013)
Cancer stem cells: The challenges ahead
Jan Paul Medema
NATURE CELL BIOLOGY (2013)
Epigenetic and genetic features of 24 colon cancer cell lines
D. Ahmed et al.
ONCOGENESIS (2013)
Structure-Based Design of a Novel Series of Potent, Selective Inhibitors of the Class I Phosphatidylinositol 3-Kinases
Adrian L. Smith et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype
Sara Ricardo et al.
JOURNAL OF CLINICAL PATHOLOGY (2011)
mTOR: from growth signal integration to cancer, diabetes and ageing
Roberto Zoncu et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)
The Cancer Stem Cell Hypothesis: Failures and Pitfalls
Maryam Rahman et al.
NEUROSURGERY (2011)
mTOR and cancer: many loops in one pathway
Alejo Efeyan et al.
CURRENT OPINION IN CELL BIOLOGY (2010)
Targeting Breast Cancer Stem Cells
Suling Liu et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
FDA Approval Summary: Temsirolimus as Treatment for Advanced Renal Cell Carcinoma
Virginia E. Kwitkowski et al.
ONCOLOGIST (2010)
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Piyush B. Gupta et al.
CELL (2009)
ELDA: Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays
Yifang Hu et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2009)
The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations
Anna Dubrovska et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Regulation of Mammary Stem/Progenitor Cells by PTEN/Akt/β-Catenin Signaling
Hasan Korkaya et al.
PLOS BIOLOGY (2009)
Targeting phosphoinositide 3-kinase - Moving towards therapy
Romina Marone et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2008)
The epithelial-mesenchymal transition generates cells with properties of stem cells
Sendurai A. Mani et al.
CELL (2008)
The eIF4E RNA regulon promotes the Akt signaling pathway
Biljana Culjkovic et al.
JOURNAL OF CELL BIOLOGY (2008)
Control of eIF4E cellular localization by eIF4E-binding proteins, 4E-BPs
Liwei Rong et al.
RNA (2008)
Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy
Christine M. Fillmore et al.
BREAST CANCER RESEARCH (2008)
Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance
Jiangbing Zhou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism
X. Wan et al.
ONCOGENE (2007)
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Jeffrey A. Engelman et al.
NATURE REVIEWS GENETICS (2006)
mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt
KE O'Reilly et al.
CANCER RESEARCH (2006)
Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties
D Ponti et al.
CANCER RESEARCH (2005)
High frequency of mutations of the PIK3CA gene in human cancers
Y Samuels et al.
SCIENCE (2004)
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells
G Dontu et al.
GENES & DEVELOPMENT (2003)
Prospective identification of tumorigenic breast cancer cells
M Al-Hajj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
PTEN coordinates G1 arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model
LP Weng et al.
HUMAN MOLECULAR GENETICS (2001)
分享论文
